Attention-deficit hyperactivity disorder (ADHD) is one of the most prevalent mental conditions among children, with approximately 6 million children aged 3 to 17 diagnosed with ADHD.
This disorder is typically identified during childhood and frequently persists into adulthood. In the U.S., there are an estimated 8.7 million adults living with ADHD. Vyvanse is one of the stimulants available for the treatment of ADHD, helping patients to regulate attention and control impulses. For adults living with ADHD, understanding how these stimulants can affect them is vital.
“What’s the impact of Vyvanse sex drive?” “Is this side effect permanent?” Read on to get answers to such questions and the causes, signs and strategies to navigate fluctuations in libido associated with Vyvanse.
Table of Contents
What is Vyvanse?
Trade name: Lisdexamfetamine
Generic name: Vyvanse
Vyvanse is a long-acting amphetamine medication FDA-approved belonging to the class of medications known as central nervous system stimulants and is primarily used in the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder and off-label uses like narcolepsy.
Once ingested, Vyvanse (Lisdexamfetamine) is converted into its active form, Dextroamphetamine, in the body. Dextroamphetamine increases neurotransmitters dopamine and norepinephrine levels in the brain, improving attention, focus, and impulse control. This mechanism helps manage symptoms of attention deficit hyperactivity disorder (ADHD).
Vyvanse Medical Uses
Beyond its FDA-approved uses, healthcare providers may explore off-label applications based on individual patient needs. Uses of Vyvanse include:
Vyvanse FDA-Approved Uses
- Attention Deficit Hyperactivity Disorder (ADHD): Vyvanse is FDA-approved for the treatment of ADHD in both children (6 years and older) and adults. It helps improve attention, focus, and impulse control.
- Binge Eating Disorder (BED): Vyvanse is also FDA-approved for the treatment of moderate to severe binge eating disorder in adults.4 It helps reduce the frequency of binge-eating episodes.
Vyvanse Off-Label Uses
- Excessive Daytime Sleepiness/Narcolepsy: Some healthcare providers may prescribe Vyvanse off-label to address excessive daytime sleepiness associated with conditions like narcolepsy.
- Depression with Fatigue: In some cases, Vyvanse might be prescribed off-label for individuals with depression who also experience significant fatigue or lack of energy.
Vyvanse Sex Drive: Why Causes Changes in Libido?
Although the exact mechanisms underlying Vyvanse-induced alterations in libido remain unclear, the clinical ramifications of this side effect involve a multifaceted interaction among neurobiological, psychosocial and dosage-related factors such as:
Vyvanse-Driven Neurobiological Mechanisms
- Dopaminergic Stimulation: Vyvanse increases dopamine levels in the brain, improving focus and attention. However, dopamine also plays a role in the reward system and arousal. Higher dopamine levels may lead to increased focus on tasks but potentially increase interest in sexual activities.
- Norepinephrine Influence: Norepinephrine helps regulate human sexual behavior; thus, changes in norepinephrine levels can influence sympathetic nervous system activity, potentially increasing sexual response and desire.
- Epinephrine Changes: Unlike the two previous neurotransmitters, higher serotonin levels are associated with decreased arousal and Vyvanse sex drive.
Given this, Lisdexamfetamine could potentially have a dual impact on sexual behavior. On the one hand, increasing dopamine levels might stimulate this behavior. On the other hand, elevating serotonin levels could potentially exert a suppressing effect.
Dose-Dependent Effects
Stimulants side effects are dose-dependent, thus Vyvanse’s impact on a person’s sex life seems also to depend on the dosage.
Lower doses may have a higher likelihood of stimulating male sexual libido, while chronic, high-dose misuse of Vyvanse or other amphetamine ADHD medications may lead to issues with libido and sexual function. Adjusting dosage under clinical supervision allows for balancing benefits and side effects.
Vyvanse Sex Drive Changes in Men
The impact of Vyvanse (Lisdexamfetamine) on sex drive can vary between males and females due to differences in hormonal and physiological factors:
Vyvanse Erectile Dysfunction
The influence of amphetamine action on peripheral circulation is identified as a potential contributor to erectile dysfunction (ED) in men using Vyvanse. This occurs through the constriction of smaller blood vessels, such as the helicine arteries, by amphetamines. However, Vyvanse prescribing instructions by the FDA reported only 2.6% of the males experienced erectile dysfunction while taking this stimulant.
Vyvanse Sex Drive Changes in Women
Vyvanse’s impact on female sexuality is unclear, with reported side effects including reduced desire, arousal and orgasm difficulty and sexual pain (dyspareunia). Additionally, amphetamine abuse, relevant to Vyvanse, may heighten female sexual drive, linked to risky behavior and adverse health outcomes,
Tips and Vyvanse Alternatives
When changes in sex drive while taking Vyvanse sex drive persist, it’s essential to consider alternative treatment options. Discussing these alternatives with your healthcare provider allows a comprehensive exploration of strategies tailored to individual needs. Here’s a closer look at potential alternatives:
- Non-Stimulant Options: Explore non-stimulant medications, such as Atomoxetine (Strattera) or Guanfacine (Intuniv), which may have different side effect profiles, including potential effects on libido.
- Behavioral Therapy: Behavioral interventions, including cognitive-behavioral therapy (CBT) can complement medication and address ADHD symptoms
- Dietary Modifications: Consider dietary changes or supplements that support focus and attention, i.e., omega-3 fatty acids.
- Regular Exercise: Exercise promotes physical health and can positively impact mood and cognitive function, potentially reducing the need for high doses of ADHD medications.
- Hormonal Evaluations: Consider evaluations of hormonal levels to rule out or address any hormonal imbalances that may contribute to changes in libido.
Vyvanse Sex Drive Final Considerations
Recognizing the dual effects on libido and sexual pleasure while taking Vyvanse underscores the importance of open communication with healthcare providers. Individual responses vary, emphasizing the need for tailored approaches in ADHD treatment. Discussing these nuances with a doctor is crucial, ensuring a personalized strategy that optimizes therapeutic benefits and well-being.
People Also Ask
Does Vyvanse take away your sex drive?
Vyvanse can potentially affect sex drive. Individuals may experience changes in libido as a side effect. It’s essential to discuss any concerns with a healthcare professional who can provide personalized guidance based on your specific situation.
Do ADHD meds increase sex drive?
ADHD medications can impact desire. Vyvanse sex drive may have varying effects. Some individuals may experience an increase, while others may notice changes. Consult with a healthcare professional to discuss any concerns or side effects.
Do stimulants affect sex drive?
Stimulant medications, like those for ADHD, can impact sex drive differently for individuals. Some may experience changes, including an increase or decrease. Discuss any concerns or side effects with a healthcare professional for advice on managing your situation.
Page Sources
- Data and statistics about ADHD | CDC. (2022, June 8). Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/adhd/data.html
- Schein, J., Adler, L. A., Childress, A., Gagnon-Sanschagrin, P., Davidson, M., Kinkead, F., Cloutier, M., Guérin, A., & Lefèbvre, P. (2022). Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. Journal of Managed Care & Specialty Pharmacy, 28(2), 168–179. https://doi.org/10.18553/jmcp.2021.21290
- Martin, D. (2023b, July 31). Amphetamine. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK556103/
- Research, C. F. D. E. A. (2023, August 28). FDA approves multiple generics of ADHD and BED treatment. U.S. Food And Drug Administration. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-multiple-generics-adhd-and-bed-treatment
- Aguilar, A. C., Frange, C., Pimentel Filho, L. H., Reis, M. J., Tufik, S., & Coelho, M. S. (2020). Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: A case series. Brazilian Journal of Psychiatry, 42(3), 314-316. https://doi.org/10.1590/1516-4446-2019-0544
- Pary, R., Scarff, J. R., Jijakli, A., Tobias, C., & Lippmann, S. (2015). A Review of Psychostimulants for Adults With Depression. Federal Practitioner, 32(Suppl 3), 30S. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375494/
- Loi, B., Sahai, M. A., De Luca, M. A., Shiref, H., & Opacka-Juffry, J. (2020). The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP). Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.00806
- Herat, L. Y., Schlaich, M. P., & Matthews, V. B. (2019). Sympathetic stimulation with norepinephrine may come at a cost. Neural Regeneration Research, 14(6), 977-978. https://doi.org/10.4103/1673-5374.250576
- Croft, H. A. (2017). Understanding the role of serotonin in female hypoactive sexual desire disorder and treatment options. The Journal of Sexual Medicine, 14(12), 1575–1584. https://doi.org/10.1016/j.jsxm.2017.10.068
- Kolar, D., Keller, A., Golfinopoulos, M., Cumyn, L., Syer, C., & Hechtman, L. (2008). Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 4(2), 389-403. https://doi.org/10.2147/ndt.s6985
- Office of the Commissioner. (2021, May 25). Vyvanse (lisdexamfetamine dimesylate). U.S. Food And Drug Administration. https://www.fda.gov/advisory-committees/vyvanse-lisdexamfetamine-dimesylate
- Holder, M. K., Hadjimarkou, M. M., Zup, S. L., Blutstein, T., Benham, R. S., McCarthy, M. M., & Mong, J. A. (2010). Methamphetamine facilitates female sexual behavior and enhances neuronal activation in the medial amygdala and ventromedial nucleus of the hypothalamus. Psychoneuroendocrinology, 35(2), 197–208. https://doi.org/10.1016/j.psyneuen.2009.07.007
Retrieved on February 27, 2024.